This report clarifies the prognostic factors for survival in localized non-Hodgkin's lymphoma (NHL) of the head and neck and defines optimal regimens for this disease. One hundred-seven untreated patients with Stage I or II NHL of the head and neck were treated with involved field radiation therapy
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas
โ Scribed by Luca Arcaini; Michele Merli; Francesco Passamonti; Raffaele Bruno; Ercole Brusamolino; Paolo Sacchi; Sara Rattotti; Ester Orlandi; Elisa Rumi; Virginia Ferretti; Silvia Rizzi; Erika Meli; Cristiana Pascutto; Marco Paulli; Mario Lazzarino
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 126 KB
- Volume
- 85
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Combination chemotherapy consisting of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, and bleomycin (MACOP-B) has been frequently used for the treatment of non-Hodgkin's lymphoma. This randomized study was undertaken to assess the efficacy and toxicity of th
## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-